
|Objective-specific relevance of the checklist items    | Disease <br> Freedom | Case <br> Detection | Prevalence <br> Estimation  | Early <br> Detection
| :---          |  :---: | :---: | :---:  | :---: |
|**1. BACKGROUND**||||
| 1.1 Hazard| :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
| 1.2 Geographical area|:heavy_check_mark:| :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:|
| 1.3 Susceptible population |:heavy_check_mark:| :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:|
| 1.4 Historical situation |:heavy_check_mark:| :heavy_check_mark: | :heavy_minus_sign:| :heavy_minus_sign:|
| 1.5 Surveillance purpose |:heavy_check_mark:| :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:|
| 1.6 Surveillance objective |:heavy_check_mark:| :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:|
| 1.7 Risk characteristics |:heavy_check_mark:| :heavy_check_mark: | :heavy_minus_sign:| :heavy_check_mark:|
| 1.8 Legal requirements & actions taken as a result of finding | :heavy_check_mark:| :heavy_check_mark: |:heavy_check_mark:|:heavy_minus_sign:|
| 1.9 Institutions involved & financing |:heavy_minus_sign:|:heavy_minus_sign:|:heavy_minus_sign:|:heavy_minus_sign:|
| 1.10 Identification of surveillance components |:heavy_check_mark:| :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| 
| 1.11 Population strata not covered |:heavy_check_mark:| :heavy_check_mark: |:heavy_check_mark:|:heavy_minus_sign:|
|**2. COMPONENT CHARACTERISTICS**||||
| 2.1 Data collection point | :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
| 2.2 Surveillance approach | :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
| 2.3 Type of hazard indicator |:heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
| 2.4 Type of material collected | :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
| 2.5 Case definition | :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
|**3. TARGET POPULATION**||||
| 3.1 Target criteria | :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
| 3.2 Population coverage | :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
|**4. ENHANCEMENTS**||||
| 4.1 Enhancements | :heavy_minus_sign: | :heavy_minus_sign:| :heavy_minus_sign:| :heavy_minus_sign:|
|**5. TESTING PROTOCOL**||||
| 5.1 Pooling | :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
| 5.2 Screening/first test | :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
| 5.3 Confirmatory/ second test |:heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
| 5.4. Accuracy of the testing protocol | :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
|**6. STUDY DESIGN**||||
| 6.1 Sampling design| :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
| 6.2 Number of target units in the target population  | :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
|**7. SAMPLING STRATEGY**||||
| 7.1 Sampling at the primary sampling unit level| :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
| 7.2 Sampling at the secondary sampling unit level  | :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
| 7.3 Sample allocation at the primary and secondary levels  |:heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
| 7.4 Riskâˆ’based allocation | :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
| 7.5 Sample size | :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
| 7.6 Sample collection timeline | :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
| 7.7 Who collects the samples | :heavy_minus_sign:| :heavy_check_mark:| :heavy_minus_sign:|  :heavy_minus_sign:|
|**8. TIMELINESS**||||
| 8.1 Time from sampling to report | :x: | :heavy_minus_sign:| :heavy_minus_sign:| :heavy_minus_sign:|
| 8.2 Time from confirmation to action | :x: |:heavy_minus_sign:| :x:| :heavy_minus_sign:| 
|**9. RESULTS**||||
| 9.1 Number of epidemiological units investigated | :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
| 9.2 Test results (per stratum) | :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
| 9.3 Surveillance outcomes (objective dependent) |:heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
|9.4 Findings in relation to historical knowledge, trend | :heavy_check_mark: | :heavy_minus_sign:| :heavy_check_mark:| :heavy_minus_sign:|
|**10. INTERPRETATION**||||
| 10.1 Surveillance interpretation| :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|
|**11. REFERENCES**||||
| 11.1 References | :heavy_check_mark: | :heavy_check_mark:| :heavy_check_mark:| :heavy_check_mark:|








 







